Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Feb;41(2):326–330. doi: 10.1128/aac.41.2.326

Experimental evaluation of possible new short-term drug regimens for treatment of multibacillary leprosy.

D K Banerjee 1, R D McDermott-Lancaster 1, S McKenzie 1
PMCID: PMC163709  PMID: 9021187

Abstract

Groups of nude mice, with both hind footpads infected with 10(8) Mycobacterium leprae organisms, were treated with 4-week courses of different drug combinations. The effect treatment on each group was evaluated by subinoculating footpad homogenates from the treated mice into groups of normal and nude mice for subsequent regrowth, assessed 1 year later. A combination of rifampin (RMP) with clarithromycin (CLARI), minocycline (MINO), and ofloxacin (OFLO) resulted in the complete killing of M. leprae after 3 weeks of treatment. A combination of sparfloxacin (SPAR) and RMP also resulted in a similar bactericidal effect after 3 weeks of treatment. Other drug combinations showed variable effects. Very little or no effect was observed with any regimen if the treatment was given for less than 2 weeks. World Health Organization (WHO) multidrug therapy (MDT) given for 8 weeks was as effective as the two combinations described above. The results suggest that multidrug combinations consisting of RMP-OFLO (or SPAR)-CLARI (and/or MINO) are as effective as the WHO MDT for the treatment of experimental leprosy. Moreover, they imply that these combinations, which were found to be active in a 4-week experimental treatment protocol, could be administered as treatment to patients for a period of time shorter than the present 2-year regimen without a loss of effectiveness.

Full Text

The Full Text of this article is available as a PDF (172.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banerjee D. K., McDermott-Lancaster R. D. An experimental study to evaluate the bactericidal activity of ofloxacin against an established Mycobacterium leprae infection. Int J Lepr Other Mycobact Dis. 1992 Sep;60(3):410–415. [PubMed] [Google Scholar]
  2. Chan G. P., Garcia-Ignacio B. Y., Chavez V. E., Livelo J. B., Jimenez C. L., Parrilla M. L., Franzblau S. G. Clinical trial of clarithromycin for lepromatous leprosy. Antimicrob Agents Chemother. 1994 Mar;38(3):515–517. doi: 10.1128/aac.38.3.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chan G. P., Garcia-Ignacio B. Y., Chavez V. E., Livelo J. B., Jimenez C. L., Parrilla M. L., Franzblau S. G. Clinical trial of sparfloxacin for lepromatous leprosy. Antimicrob Agents Chemother. 1994 Jan;38(1):61–65. doi: 10.1128/aac.38.1.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Colston M. J., Hilson G. R., Banerjee D. K. The "proportional bactericidal test": a method for assessing bactericidal activity in drugs against Mycobacterium leprae in mice. Lepr Rev. 1978 Mar;49(1):7–15. [PubMed] [Google Scholar]
  5. Fajardo T. T., Jr, Villahermosa L. G., dela Cruz E. C., Abalos R. M., Franzblau S. G., Walsh G. P. Minocycline in lepromatous leprosy. Int J Lepr Other Mycobact Dis. 1995 Mar;63(1):8–17. [PubMed] [Google Scholar]
  6. Franzblau S. G., Parrilla M. L., Chan G. P. Sparfloxacin is more bactericidal than ofloxacin against Mycobacterium leprae in mice. Int J Lepr Other Mycobact Dis. 1993 Mar;61(1):66–69. [PubMed] [Google Scholar]
  7. Gelber R. H. Activity of minocycline in Mycobacterium leprae-infected mice. J Infect Dis. 1987 Jul;156(1):236–239. doi: 10.1093/infdis/156.1.236. [DOI] [PubMed] [Google Scholar]
  8. Gelber R. H., Iranmanesh A., Murray L., Siu P., Tsang M. Activities of various quinolone antibiotics against Mycobacterium leprae in infected mice. Antimicrob Agents Chemother. 1992 Nov;36(11):2544–2547. doi: 10.1128/aac.36.11.2544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gelber R. H., Murray L. P., Siu P., Tsang M., Rea T. H. Efficacy of minocycline in single dose and at 100 mg twice daily for lepromatous leprosy. Int J Lepr Other Mycobact Dis. 1994 Dec;62(4):568–573. [PubMed] [Google Scholar]
  10. Grosset J. H., Guelpa-Lauras C. C., Perani E. G., Beoletto C. Activity of ofloxacin against Mycobacterium leprae in the mouse. Int J Lepr Other Mycobact Dis. 1988 Jun;56(2):259–264. [PubMed] [Google Scholar]
  11. Halvorson H. O., Ziegler N. R. Application of Statistics to Problems in Bacteriology: I. A Means of Determining Bacterial Population by the Dilution Method. J Bacteriol. 1933 Feb;25(2):101–121. doi: 10.1128/jb.25.2.101-121.1933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hastings R. C., Chehl S. K. Chemotherapy of leprosy in multibacillary nude mice. Indian J Lepr. 1991 Jul-Dec;63(3-4):350–355. [PubMed] [Google Scholar]
  13. Holmes I. B., Hilson G. R. The effect of rifampicin and dapsone on experimental Mycobacterium leprae infections: minimum inhibitory concentrations and bactericidal action. J Med Microbiol. 1972 May;5(2):251–261. doi: 10.1099/00222615-5-2-251. [DOI] [PubMed] [Google Scholar]
  14. Ji B., Jamet P., Perani E. G., Bobin P., Grosset J. H. Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy. J Infect Dis. 1993 Jul;168(1):188–190. doi: 10.1093/infdis/168.1.188. [DOI] [PubMed] [Google Scholar]
  15. Ji B., Perani E. G., Grosset J. H. Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice. Antimicrob Agents Chemother. 1991 Mar;35(3):579–581. doi: 10.1128/aac.35.3.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ji B., Perani E. G., Petinom C., Grosset J. H. Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice. Antimicrob Agents Chemother. 1996 Feb;40(2):393–399. doi: 10.1128/aac.40.2.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ji B., Perani E. G., Petinon C., Grosset J. H. Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice. Int J Lepr Other Mycobact Dis. 1992 Dec;60(4):556–561. [PubMed] [Google Scholar]
  18. McDermott-Lancaster R. D., Banerjee D. K. Activity of sparfloxacin against Mycobacterium leprae measured by the proportional bactericidal test. Int J Lepr Other Mycobact Dis. 1993 Dec;61(4):605–608. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES